Tissue Regenix Group plc (LON:TRX – Get Free Report) shares hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as GBX 37 ($0.48) and last traded at GBX 37 ($0.48), with a volume of 78975 shares trading hands. The stock had previously closed at GBX 40.50 ($0.53).
Tissue Regenix Group Price Performance
The company has a current ratio of 4.03, a quick ratio of 2.36 and a debt-to-equity ratio of 31.16. The stock has a market cap of £33.36 million, a PE ratio of -38.20 and a beta of 1.61. The business has a 50-day moving average price of GBX 51.88 and a 200 day moving average price of GBX 55.79.
About Tissue Regenix Group
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Featured Articles
- Five stocks we like better than Tissue Regenix Group
- Buy P&G Now, Before It Sets A New All-Time High
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- What is a SEC Filing?
- Alphabet’s Officially In A Bear Market—Time To Buy?
- How to Capture the Benefits of Dividend Increases
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
